Inari Medical Inc
General ticker "NARI" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $3.1B
Inari Medical Inc does not follow the US Stock Market performance with the rate: -6.5%.
Estimated limits based on current volatility of 2.6%: low 53.39$, high 56.28$
Factors to consider:
- US accounted for 95.2% of revenue in the fiscal year ended 2023-12-31
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [51.19$, 90.85$]
- 2023-12-31 to 2024-12-30 estimated range: [48.40$, 85.96$]
Financial Metrics affecting the NARI estimates:
- Negative: Non-GAAP EPS, $ of -0.55 <= 0.10
- Negative: Operating profit margin, % of -6.83 <= 1.03
- Negative: Operating cash flow per share per price, % of -0.38 <= 2.35
- Negative: negative Net income
- Positive: Inventory ratio change, % of 0.77 <= 1.08
- Positive: Interest expense per share, $ of 0.01 <= 0.14
Short-term NARI quotes
Long-term NARI plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $276.98MM | $383.47MM | $493.63MM |
| Operating Expenses | $266.14MM | $411.57MM | $507.66MM |
| Operating Income | $10.84MM | $-28.10MM | $-14.03MM |
| Non-Operating Income | $-0.16MM | $1.91MM | $18.28MM |
| Interest Expense | $0.29MM | $0.29MM | $0.20MM |
| R&D Expense | $51.02MM | $74.22MM | $87.53MM |
| Income(Loss) | $10.69MM | $-26.18MM | $4.25MM |
| Taxes | $0.84MM | $3.08MM | $5.88MM |
| Profit(Loss) | $9.84MM | $-29.27MM | $-1.64MM |
| Stockholders Equity | $239.21MM | $417.00MM | $464.91MM |
| Inventory | $21.05MM | $32.58MM | $42.90MM |
| Assets | $311.54MM | $504.15MM | $674.24MM |
| Operating Cash Flow | $25.49MM | $-13.97MM | $35.93MM |
| Capital expenditure | $13.64MM | $9.95MM | $6.20MM |
| Investing Cash Flow | $-51.02MM | $-195.22MM | $-58.02MM |
| Financing Cash Flow | $4.07MM | $177.14MM | $1.17MM |
| Earnings Per Share* | $0.20 | $-0.55 | $-0.03 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.